Evidence map›Paper›PMID 30728219›Full record

ArticleDiabetes care2019

Dairy Product Intake and Risk of Type 2 Diabetes in EPIC-InterAct: A Mendelian Randomization Study.

Linda E T Vissers, Ivonne Sluijs, Yvonne T van der Schouw, Nita G Forouhi, Fumiaki Imamura, Stephen Burgess, Aurelio Barricarte, Heiner Boeing, Catalina Bonet, Maria-Dolores Chirlaque and 26 more

Open access · greenAbstract read
In one paragraph

Article in Diabetes care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 4 pooled it
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 4 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors at 20 institutions in 9 countries.

Linda E T VissersJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.ORCID 0000-0001-9044-0744
Ivonne SluijsJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands i.sluijs-2@umcutrecht.nl.ORCID 0000-0001-7758-4911
Yvonne T van der SchouwJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Nita G ForouhiMRC Epidemiology Unit, University of Cambridge, Cambridge, U.K.ORCID 0000-0002-5041-248X
Fumiaki ImamuraMRC Epidemiology Unit, University of Cambridge, Cambridge, U.K.
Stephen BurgessDepartment of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, U.K.
Aurelio BarricarteNavarre Public Health Institute (ISPN), Pamplona, Spain.
Heiner BoeingGerman Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Catalina BonetUnit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Program, Institut Català d'Oncologia, Barcelona, Spain.
Maria-Dolores ChirlaqueDepartment of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, University of Murcia, Murcia, Spain.
Guy FagherazziCentre for Research in Epidemiology and Population Health (CESP), UMR1018, INSERM, Institut Gustave Roussy, Paris South University-Paris-Saclay University, Villejuif, France.ORCID 0000-0001-5033-5966
Paul W FranksLund University, Malmö, Sweden.ORCID 0000-0002-0520-7604
Heinz FreislingSection of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France.
Marc J GunterSection of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France.
J Ramón QuirósPublic Health Directorate, Asturias, Spain.
Daniel B IbsenSection for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.
Rudolf KaaksGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Timothy KeyUniversity of Oxford, Oxford, U.K.
Kay T KhawDepartment of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, U.K.ORCID 0000-0002-8802-2903
Tilman KühnGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Olatz MokoroaCIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Peter M NilssonLund University, Malmö, Sweden.
Kim OvervadDepartment of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
Valeria PalaEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Domenico PalliCancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
Salvatore PanicoDipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
Carlotta SacerdoteUnit of Cancer Epidemiology, University Hospital "Città della Salute e della Scienza," University of Turin, and Center for Cancer Prevention (CPO), Torino, Italy.
Annemieke M W SpijkermanNational Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Anne TjonnelandDanish Cancer Society Research Center, Copenhagen, Denmark.
Rosario TuminoAzienda Sanitaria Provinciale (ASP) Ragusa, Ragusa, Italy.
Miguel Rodríguez-BarrancoCIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Olov RolandssonUmeå University, Umeå, Sweden.
Elio RiboliSchool of Public Health, Imperial College London, London, U.K.
Stephen J SharpMRC Epidemiology Unit, University of Cambridge, Cambridge, U.K.
Claudia LangenbergMRC Epidemiology Unit, University of Cambridge, Cambridge, U.K.
Nicholas J WarehamMRC Epidemiology Unit, University of Cambridge, Cambridge, U.K.
MRC Epidemiology Unit · GBUtrecht University · NLCentre international de recherche sur le cancer · FRGerman Cancer Research Center · DELund University · SEPiedmont Reference Center for Epidemiology and Cancer Prevention · ITUniversity of Cambridge · GBAalborg University Hospital · DKAarhus University · DKAgenzia Regionale Sanitaria della Puglia · ITBiogipuzkoa Health Research Institute · ESCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESDanish Cancer Society · DKFederico II University Hospital · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITGerman Institute of Human Nutrition · DEGobierno del Principado de Asturias · ESImperial College London · GBInserm · FRInstitut Català d'Oncologia · ES

Funding

British Heart Foundation RG/13/13/30194British Heart Foundation RG/18/13/33946Cancer Research UK 14136Medical Research Council G0401527Medical Research Council G1000143Medical Research Council MC_UU_00002/7Medical Research Council MC_UU_12015/1Medical Research Council MC_UU_12015/5Medical Research Council MR/N003284/1Wellcome Trust 204623/Z/16/ZWellcome Trust LEAP 205212/Z/16/ZWorld Health Organization 001
6 · The paper itself

Abstract

objectiveTo estimate the causal association between intake of dairy products and incident type 2 diabetes. RESEARCH DESIGN AND

methodsThe analysis included 21,820 European individuals (9,686 diabetes cases) of the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study. Participants were genotyped, and rs4988235 (LCT-12910C>T), a single nucleotide polymorphism (SNP) for lactase persistence (LP) that enables digestion of dairy sugar, i.e., lactose, was imputed. Baseline dietary intakes were assessed with diet questionnaires. We investigated the associations between imputed SNP dosage for rs4988235 and intake of dairy products and other foods through linear regression. Mendelian randomization (MR) estimates for the milk-diabetes relationship were obtained through a two-stage least squares regression.

resultsEach additional LP allele was associated with a higher intake of milk (β 17.1 g/day, 95% CI 10.6-23.6) and milk beverages (β 2.8 g/day, 95% CI 1.0-4.5) but not with intake of other dairy products. Other dietary intakes associated with rs4988235 included fruits (β -7.0 g/day, 95% CI -12.4 to -1.7 per additional LP allele), nonalcoholic beverages (β -18.0 g/day, 95% CI -34.4 to -1.6), and wine (β -4.8 g/day, 95% CI -9.1 to -0.6). In instrumental variable analysis, LP-associated milk intake was not associated with diabetes (hazard ratio

conclusionsrs4988235 was associated with milk intake but not with intake of other dairy products. This MR study does not suggest that milk intake is associated with diabetes, which is consistent with previous observational and genetic associations. LP may be associated with intake of other foods as well, but owing to the modest associations, we consider it unlikely that this caused the observed null result.

Indexed as

Dairy ProductsAdultAnimalsCase-Control StudiesCohort StudiesDiabetes Mellitus, Type 2EatingFemaleGene-Environment InteractionGenotypeHumansIncidenceLactaseMaleMendelian Randomization AnalysisMiddle AgedLactase

Identifiers

PMID30728219
PMCPMC7340535
OpenAlexW2912846750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.